Synchrony Financial (SYF-PB) Research & Development (2013 - 2026)

Synchrony Financial has reported Research & Development for 14 years, with the latest figure at $262.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 19.63% year-over-year to $262.0 million; the trailing twelve-month figure through Mar 2026 stood at $942.0 million (up 12.68% YoY), and the FY2025 full-year result was $899.0 million, up 11.96% from the prior year.
• Research & Development for Q1 2026 stood at $262.0 million, up from $239.0 million in the prior quarter.
• The five-year high for Research & Development was $262.0 million in Q1 2026, with the low at $145.0 million in Q1 2022.
• Historically, Research & Development has averaged $194.1 million across 5 years, with a median of $190.0 million in 2023.
• Annual changes were most pronounced in 2025 — Research & Development gained 3.86% — and 2026, when it climbed 19.63%.
• Synchrony Financial's Research & Development stood at $165.0 million in 2022, then gained by 15.15% to $190.0 million in 2023, then climbed by 8.95% to $207.0 million in 2024, then grew by 15.46% to $239.0 million in 2025, then grew by 9.62% to $262.0 million in 2026.
• The last three Research & Development figures came in at $262.0 million (Q1 2026), $239.0 million (Q4 2025), and $226.0 million (Q3 2025), per Business Quant data.